Chase Denecke is CEO of Bootstrap Bio, a company working on bringing the first embryo gene editing service to market.

Chase's interest in genetics began with his work at Genomic Prediction, the world's first embryo selection company, continued at Baby Steps IVF, a company dedicated to helping IVF patients find better clinics, and culminated with the founding of Bootstrap Bio, a company dedicated to bringing effective, affordable embryo gene editing to market.